The possible pathophysiological roles of LNX4 were initially analyzed in hepatocellular carcinoma (HCC), which is the major subtype of liver cancer that accounts for approximately 80% of all cases [159,160]. Here, PDZRN4 is linked to hepatocellular carcinoma.